Cognitive performance of healthy young rats following chronic donepezil administration

Psychopharmacology (Berl). 2008 May;197(4):661-73. doi: 10.1007/s00213-008-1084-0. Epub 2008 Feb 29.

Abstract

Rationale: Experimental studies have investigated the effects of chronic donepezil treatment on the behavioral deficits elicited by reduced activity or the loss of cholinergic neurons that occurs in aging or in models of dementia. However, few studies have analyzed the effects of chronic donepezil treatment on the cognitive functions of intact animals.

Objectives: The cognitive functions of healthy young rats treated chronically with the acetylcholinesterase inhibitor donepezil were evaluated using a wide behavioral test battery.

Results: Chronic treatment with donepezil ameliorated memory functions and explorative strategies, speeded up the acquisition of localizing knowledge, augmented responsiveness to the context, and reduced anxiety levels. However, it did not affect spatial span, modify motivational levels, or influence associative learning.

Conclusions: The present findings show the specific profile of donepezil action on cognitive functions in the presence of unaltered cholinergic neurotransmission systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arousal / drug effects
  • Avoidance Learning / drug effects
  • Behavior, Animal / drug effects*
  • Choice Behavior / drug effects
  • Cholinesterase Inhibitors / pharmacology*
  • Cognition / drug effects*
  • Donepezil
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Escape Reaction / drug effects
  • Indans / pharmacology*
  • Male
  • Maze Learning / drug effects
  • Mental Recall / drug effects
  • Motivation
  • Motor Activity / drug effects
  • Nootropic Agents / pharmacology*
  • Orientation / drug effects
  • Piperidines / pharmacology*
  • Rats
  • Rats, Wistar
  • Reaction Time / drug effects
  • Serial Learning / drug effects

Substances

  • Cholinesterase Inhibitors
  • Indans
  • Nootropic Agents
  • Piperidines
  • Donepezil